Long-term Use of Dual Antiplatelets for the Secondary Prevention of Atherothrombotic Events: Meta-analysis of Randomized Controlled Trials - Zaher Fanari, MD

↳ This is a section part of Moment: CRT 2016 Coronary - CTO Academy - Best Abstracts

Add this Moment to your Passport

Learn from this moment and keep it forever.

add to passport

$8.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Long-term Use of Dual Antiplatelets for the Secondary Prevention of Atherothrombotic Events: Meta-analysis of Randomized Controlled Trials presented by Zaher Fanari, MD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.

add to passport

$8.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows

Session Name: CTO Academy - Best Abstracts

Track: Coronary

Learning Objectives

Update in advances in CTO

Other Components in this Moment

Overview

Real-world Clinical Experience with An Everolimus-eluting Platinum Chromium Stent with an Abluminal Biodegradable Polymer: A Report From The Swedish Coronary - Giovanna Sarno

Duration of DAPT Following Drug-eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials - Abhishek Sharma, MD

Gender Disparities in ST-Elevation Myocardial Infarction Care and Outcomes in Emerging Countries: A Global Lumen Organization for Women Initiative and Call to Action - Ido Haimi, MD

Long-term Use of Dual Antiplatelets for the Secondary Prevention of Atherothrombotic Events: Meta-analysis of Randomized Controlled Trials - Zaher Fanari, MD